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Demographic changes and improvements in health care are projected to result in dramatic
increases in the prevalence of dementia. Alzheimer’s disease is widely considered to be
the primary cause of dementia – a disease for which there is currently no cure nor effective
treatment, and for which it is thought that little can be done to mitigate risk. However, an
increasing understanding of the role and extent of vascular contributions to the develop-
ment of dementia, and appreciation of the interactions between stroke and Alzheimer’s
disease, suggest that targeting vascular risk factors may be very beneficial in reducing the
impact of dementia. We also describe how active stimulation of the brain throughout the
life course builds cognitive reserve that can offset or compensate for cognitive decline in
later life. Finally, we discuss the implications of these emerging approaches for dementia
prevention and advocate for the urgent implementation of more extensive public health
strategies to improve vascular health.
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INTRODUCTION
Dementia is a debilitating syndrome of brain disorders distin-
guished by a progressive decline in cognitive functions to the
point where everyday activities are compromised. Demographic
changes and improvements in health care are driving dramatic
increases in the numbers and proportion of people reaching old
age, and advanced age is a powerful risk factor for developing
dementia. As a consequence, a staggering growth in the number
of people with dementia is projected, reaching 65.7 million glob-
ally by 2030 (World Health Organization and Alzheimer’s Disease
International, 2012). It is difficult to understate the health and
economic burden that this will generate. A range of degenera-
tive and other neuropathological processes can result in dementia,
but Alzheimer’s disease is widely considered to be the most fre-
quent cause – although this view is changing, as we will discuss.
Alzheimer’s disease is defined by a signature brain pathology
characterized by amyloid peptide deposits in blood vessels and
in plaques, by the formation of neurofibrillary tangles, and by
neurodegeneration. The cause of late-onset Alzheimer’s disease
is unknown and attempts to develop pharmacological solutions
have largely focused on eliminating the amyloid deposition that is
hypothesized to be neurotoxic. However, the causal role of amyloid
deposition has been questioned (de la Torre, 2004) and anti-
amyloid immunotherapy drugs that clear amyloid fail to impact
cognitive or functional outcomes (BBC News, 2012; Teich and
Arancio, 2012). Extensive trials of ginkgo biloba extracts that
in preclinical studies exhibit neuroprotective and anti-amyloid
actions have also failed to show clinical efficacy (Vellas et al.,
2012). Regrettably, little can presently be offered to help those
who are diagnosed with Alzheimer’s disease (Spence, 2012), no
effective treatment is available, future prospects for brain repair
through approaches such as functional neurogenesis are increas-
ingly uncertain (Costandi, 2012), and it has been argued that
significant cognitive loss is incurable (de la Torre, 2010). Adding to
the negative outlook is a report from an expert independent panel
recently commissioned by the National Institutes of Health that
concluded that insufficient evidence was available to support rec-
ommendations for the modification of risk for Alzheimer’s disease
or cognitive decline (National Institutes of Health, 2010; Daviglus
et al., 2011).
This pessimistic view that dementia is largely an inevitable con-
sequence of aging is challenged by international comparisons that
show lower incidence rates in developing compared to developed
countries (Hendrie et al., 2001; World Health Organization and
Alzheimers Disease International, 2012). There are also indica-
tions that within developed countries there have been decreases
in dementia incidence over recent decades that are associated
with improvements in social and medical factors (Schrijvers et al.,
2012). Thus, dementia risk appears to be modifiable.
In this perspective we provide an overview of two areas of
active investigation that are revealing potential opportunities to
reduce the impact of the dementia epidemic: a reduction in
dementia resulting from stroke, and an expansion in cognitive
reserve. Firstly, vascular disease and stroke leading to dementia
have received less attention than Alzheimer’s disease, and “vascu-
lar dementia” is thought of as the second most common cause
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of dementia. There is however an increasing appreciation that
vascular contributions to the development of dementia are sig-
nificant (Gorelick et al., 2011) and that dementia pathogenesis is
typically complex, involving interacting vascular and degenerative
processes (Korczyn et al., 2012). This implies that vascular dis-
ease prevention may represent an effective approach to decreasing
dementia risk and delaying its onset. Secondly, the lack of a direct
relationship between the extent of brain damage or pathology
and the degree of cognitive decline evident clinically, in combina-
tion with epidemiological evidence linking resistance to cognitive
decline with extended education, social, and intellectual activity,
have led to the cognitive reserve hypothesis (Stern, 2002). Life-long
cognitive activity to enhance cognitive reserve may also represent
a promising strategy to mitigate cognitive decline and postpone
dementia.
CLINICAL STROKE AND DEMENTIA
Thomas Willis first described that dementia can result from a large
stroke in 1672 (Romàn, 2002a) and it is now well known that
stroke doubles the risk of new-onset dementia (Leys et al., 2005).
An extensive systematic review found that dementia prevalence
among persons with clinical stroke was 10% prior to first stroke
and that an additional 10% develop new dementia shortly after
first stroke (Pendlebury and Rothwell, 2009). The occurrence of a
second stroke is a powerful predictor of dementia and among per-
sons with recurrent stroke the prevalence of dementia is 30%. The
prevalence of cognitive impairment is even higher: 50% of individ-
uals exhibit deficits when assessed 3 months post-stroke (Sundar
and Adwani, 2010). Stroke can therefore initiate rapid cognitive
decline. This forms a basis for the etiology of vascular dementia
and the more recent, broader concept of vascular cognitive impair-
ment, which encompasses mild cognitive impairment resulting
from vascular disease processes through to dementia following
stroke (Hachinski et al., 2006).
COVERT STROKE, MICROEMBOLI, AND DEMENTIA
Infarcts and hemorrhages arising from stroke and other cere-
brovascular disease can vary in size, number, and location and
may or may not be associated with the clinical signs and symp-
toms of stroke when they occur. Advances in imaging technology
are revealing the widespread extent of subclinical cerebrovascular
brain injury in the general senior population, even in individuals
with no prior history of stroke. Small (<1 cm) infarcts arising from
clinically unrecognized “covert” strokes have an overall prevalence
up to fivefold that of clinical stroke, ranging from around 10%
at age 50 to almost 30% by age 85 (Vermeer et al., 2007). Cere-
bral microbleeds – the hemorrhagic counterpart of small ischemic
strokes, are also common (Jeerakathil et al., 2004; Poels et al., 2010)
with a prevalence of 6% at age 50, rising to 36% among those
aged 80 years and older. In addition to age, their frequency is also
associated with vascular risk factors (Viswanathan and Chabriat,
2006). Lesions in the white matter are even more common and
can also be observed in the brains of most individuals from age
30, the extent, and volume increasing with increasing age (DeCarli
et al., 2005). When multiple measures of vascular pathology are
included, frequencies of cerebrovascular pathology of 78% have
been reported for community-based autopsy series among persons
over 70 years (Neuropathology Group. Medical Research Council
Cognitive Function and Aging Study, 2001). These covert strokes
are not clinically silent as was earlier thought, but are associated
with cognitive deficits, particularly executive dysfunction (Wer-
ring et al., 2004; Prins et al., 2005), and memory loss (Blum et al.,
2012). Covert strokes and white matter lesions each more than
double the risk of stroke and the risk of dementia (Vermeer et al.,
2003a,b; Debette and Markus, 2010).
Further evidence for a direct role of covert ischemic stroke in
the progressive decline of cognitive function is provided by tran-
scranial Doppler studies. Monitoring the middle cerebral artery
over the course of several hours can detect spontaneous cerebral
microemboli that may arise from carotid disease and atrial fib-
rillation (Goldberg et al., 2012). Recent Doppler studies detected
cerebral microemboli in almost 40% of patients with dementia
compared to only 14% in matched controls (Purandare et al.,
2006), and over the following 2 years patients with dementia
and microemboli exhibited a twofold faster cognitive deteriora-
tion when compared to emboli-negative patients with dementia
(Purandare et al., 2012). Cerebral microemboli also arise periop-
eratively during major surgery and this may be the cause of the
postoperative cognitive impairment that occurs in over one in four
treated patients aged 60 and above (Moller et al., 1998). Conges-
tive heart failure is also a highly prevalent condition among the
elderly and cerebral microemboli combined with chronic cerebral
hypoperfusion are thought to account for the cognitive decline
that commonly accompanies heart failure (Dardiotis et al., 2012).
Based on a consideration of the prevalence and extent of the
contributions of clinical and covert stroke to the development of
dementia, it has been proposed that vascular dementia may be the
most common form of dementia (Romàn, 2002b). However, the
heterogeneity of injury arising from stroke and the importance
of the lesion site have made it difficult to define both the clinical
diagnostic criteria and the pathological criteria that can allow an
accurate quantitative evaluation of the vascular contribution to
cognitive decline (Grinberg and Heinsen, 2010).
STROKE AND ALZHEIMER’S DISEASE
In general clinical practice, Alzheimer’s disease has become syn-
onymous with dementia and “probable Alzheimer’s disease” is
the typical diagnosis given to elderly persons with dementia. But
autopsy series reveal that around one in fournon-demented elderly
persons have Alzheimer disease pathology (Schneider et al., 2007).
On the other hand, among persons who had a clinical diagno-
sis of probable Alzheimer’s disease or mild cognitive impairment,
almost half exhibited mixed Alzheimer and cerebral infarct pathol-
ogy (Schneider et al., 2009). As visible microscopic infarcts and
white matter damage were not included in this analysis, the true
proportion of mixed pathologies is likely to be significantly higher.
Furthermore, studies that combine prospective neuropsychologi-
cal examination with a neuropathological assessment at death find
that in individuals with post-mortem Alzheimer’s pathology, the
presence of deep brain infarcts is associated with a more extensive
cognitive decline prior to death (Snowdon et al., 1997). Addi-
tionally, these studies have established that macroscopic infarcts
independently reduce cognition and increase the likelihood of
dementia, and that vascular pathology may also be associated
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with episodic memory loss – the signature Alzheimer phenotype
(Schneider and Bennett, 2010). What emerges is a more com-
plex picture wherein cognitive decline and dementia are typically
associated with co-occurring, interacting Alzheimer and vascular
disease processes, each with overlapping clinical features.
It is also becoming apparent that vascular disease processes and
Alzheimer pathology interact at the level of the neurovascular unit.
As described in a recent extensive review of the field (Pimentel-
Coelho and Rivest, 2012), cerebral ischemia and hypoxia may
both increase the expression and reduce the clearance, of amyloid
proteins. Also, the deposition of Alzheimer proteins in neurons
and in the walls of small-vessels increases their susceptibility
to injury from hypoxia-ischemia. In particular, cerebral amyloid
angiopathy, in which amyloid protein accumulates in the walls of
small-vessels in the brain, causes microbleeds and may underlie
the cerebral hypoperfusion that is associated with the early stages
of cognitive decline.
VASCULAR RISK AND DEMENTIA
In view of the contribution that vascular disease processes (espe-
cially stroke) make to the development of dementia, it is not
surprising that epidemiological studies find evidence for the asso-
ciation of modifiable vascular risk factors such as mid-life hyper-
tension (Nagai et al., 2010), diabetes (Lu et al., 2009), cholesterol
(van Vliet, 2012), poor diet (Solfrizzi et al., 2011), obesity (Lee,
2011), physical inactivity (Denkinger et al., 2012), and smoking
(Rusanen et al., 2010), with increased likelihood of Alzheimer’s
disease (Patterson et al., 2007; Barnes and Yaffe, 2011). It has been
observed however (Chui et al., 2012), that the associations estab-
lished are most consistent with increased risk of dementia rather
than increased risk of Alzheimer’s disease defined by its pathol-
ogy. This also holds for depression, now accepted to be a driver of
vascular compromise and cognitive impairment (Hakim, 2011).
There is also observational data indicating that managing vas-
cular risk factors can slow cognitive decline, even among patients
with dementia (Deschaintre et al., 2009). To date randomized
controlled trials have largely failed to establish that treatment
with medications targeting vascular risk factors such as hyper-
tension, dyslipidemia, and inflammation are effective in dementia
prevention. These negative results have been attributed to method-
ological issues, most notably that the intervention trials were
underpowered for dementia, of short duration, and focused on
late rather than mid-life disease. A series of ongoing trials have
been designed to address these limitations (Mangialasche et al.,
2012; Qiu, 2012).
COGNITIVE RESERVE
It is frequently observed that individuals who are cognitively
normal prior to death can still exhibit an extensive burden of
neuropathology upon post-mortem examination. Data from stud-
ies of large cohorts of elderly people indicate that brain weight
and pathology burden only account for one third to half of the
observed variance in cognitive ability (Dowling et al., 2011). The
cognitive reserve hypothesis explains this disconnect in terms of
brain resilience due to factors such as capacity to withstand dam-
age, ability to compensate for damage through the use of alternate
networks, and remodeling and plasticity (Stern, 2006; Esiri and
Chance, 2012). Engaging in stimulating mental and physical activ-
ity throughout life is thought to increase cognitive reserve which in
turn slows cognitive decline and delays onset of dementia. There is
strong observational evidence that high versus low levels of educa-
tion protects against dementia, approximately halving risk (Meng
and D’Arcy, 2012; Prince et al., 2012). Education also protects
cognitive function in inherited early onset small vessel disease –
i.e., “pure” vascular cognitive impairment (Zieren et al., 2013).
In addition, educational history is an independent predictor of
post-stroke cognitive deficits (Ojala-Oksala et al., 2012). Partici-
pation in social networks may also be beneficial (Bennett et al.,
2006). Compelling support for the cognitive reserve hypothesis
is provided by the advantageous effect of bilingualism, but only
if the additional language is actively used. Diagnosis of demen-
tia is found to be delayed by 3–4 years when otherwise equivalent
mono and bilingual dementia cases are compared (Bialystok et al.,
2007, 2012). If the onset of dementia among the global popula-
tion could be delayed by just 2 years it has been estimated that
almost a quarter of the cases of Alzheimer’s disease expected by
the year 2050 could be avoided (Brookmeyer et al., 2007). Thus the
concept of cognitive reserve is worthy of exploration and further
study.
Cognitive training programs are actively marketed to older
adults as a way to offset age-associated cognitive decline. Results
from interventional trials indicate that cognitive training can
improve specific cognitive ability, but that the benefits are mostly
limited to the targeted outcome (Ball et al., 2002; Acevedo and
Loewenstein, 2007; Owen et al., 2010). Studies of cognitive training
and other related cognitive interventions in the elderly popula-
tion conducted to date have lacked the power and have been
too diverse in approach to establish whether such programs are
effective at delaying or preventing dementia onset (Buschert et al.,
2010).
PUBLIC HEALTH AND OTHER IMPLICATIONS
Alzheimer’s disease has become enshrined in our popular culture
and is commonly thought by the public and health professionals to
be exclusively responsible for cognitive decline and the projected
epidemic of elderly persons with dementia. In contrast, the typical
mixed pathology nature of late-onset dementia and the vascular
contribution to cognitive decline are largely unrecognized. Fur-
thermore, the view prevails that the onset of “Alzheimer’s” is a
mostly unavoidable consequence of reaching old age. This review
therefore has a number of implications.
Dementia prevention should be considered from a broader per-
spective than just “pure” Alzheimer’s disease. The potential that
vascular disease prevention offers for dementia represents a major
overlooked opportunity. Early (by mid-life) prevention and treat-
ment of the well established and highly prevalent vascular risk
factors such as hypertension and diabetes, in combination with
lifestyle changes that increase physical activity, improve diet, and
eliminate smoking are likely to significantly reduce the incidence
of dementia at the population level (Ahlskog et al., 2011; Willis
et al., 2012). Since recurrent events accelerate cognitive decline,
improvements in the secondary prevention of stroke and heart
disease are also likely to positively impact dementia rates. There
is currently no level I evidence from randomized controlled trials
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Table 1 | Interventions to reduce dementia risk.
Lifestyle* Diet* Psychosocial Pharmacotherapy*
Smoking cessation DASH-style dietc Extensive education Hypertension
Moderation of alcohol intakea Rich in vegetables and fruit Cognitive engagement Atrial fibrillation
Weight control Reduced intake of sodium Social stimulation Recurrent stroke
Physical activityb Free of trans fat Avoidance/treatment of depression Diabetes and hyperlipidemia
*Based on recommendations for the prevention of stroke (Goldstein et al., 2011).
a≤2 Drinks per day for men and ≤1 drink per day for women.
b150min per week of moderate intensity or 75min per week of vigorous intensity aerobic physical activity.
cEmphasizes consumption of fruits, vegetables, and low-fat dairy products and is reduced in saturated fat.
that support the role of vascular risk factors in dementia preven-
tion. Such evidence may not be feasible to obtain, as conducting
randomized controlled trials over many decades presents signif-
icant challenges, and it may not be possible for ethical reasons
to investigate certain vascular risk factors in intervention trials
(Kroke et al., 2003). However, the level II evidence that we have
outlined provides a strong argument for an urgent enhancement of
public health measures to improve vascular health as part of a pop-
ulation level dementia prevention strategy. Importantly, it adds
further justification for population level vascular health interven-
tions such as smoking legislation, banning trans fat, and decreasing
sodium levels in the food supply.
In addition to the gap in translating the current knowledge of
the role of vascular disease and stroke into dementia prevention,
there is also a significant gap in awareness among health profes-
sionals and the public. Physician training is necessary to develop
their ability to act as advocates and educators on healthy brain
aging (Romàn et al., 2012). Furthermore, governments, cardiovas-
cular and Alzheimer’s disease organizations, and charities should
work together to ensure that this message reaches the general
public.
We need to break down the barriers that result in research
into the disease processes that cause dementia taking separate and
largely non-communicating paths. New research networks should
be formed that bring scientists from vascular, stroke, and amy-
loid research, together with clinicians from the fields of neurology,
psychiatry,and gerontology. Such networks would establish collab-
orations to study the prevention strategies and treatments, as well
as repair modalities, that may be effective in alleviating cognitive
impairment and dementia.
A modest delay in the onset of dementia, such as what could
potentially be achievable through enhancing cognitive reserve,
can significantly reduce incidence of the disease. Public policy
should continue to promote universal education and also support
the maintenance of lifestyles that maximize physical, mental, and
social activity into advanced age. While cognitive training in late
life may not add appreciably to the reserve built over a lifetime, it
is clear that the social isolation and unstimulating environments
experienced by many elderly will negatively impact their brain
health.
The disappointing results from candidate drugs targeting
Alzheimer pathology and our emerging understanding of the
vascular contributions to cognitive decline make it increasingly
unlikely that we will be able to change the course of established
disease for the foreseeable future. However, there is much to be
gained by increasing efforts targeting diet, physical activity, vascu-
lar interventions, and enhancing cognitive reserve (Table 1). The
time to act is now.
REFERENCES
Acevedo, A., and Loewenstein, D. A.
(2007). Nonpharmacological cog-
nitive interventions in aging and
dementia. J. Geriatr. Psychiatry Neu-
rol. 20, 239–249.
Ahlskog, J. E., Geda, Y. E., Graff-
Radford, N. R., and Petersen, R. C.
(2011). Physical exercise as a preven-
tive or disease-modifying treatment
of dementia and brain aging. Mayo
Clin. Proc. 86, 876–884.
Ball, K., Berch, D. B., Helmers, K. F.,
Jobe, J. B., Leveck, M. D., Mar-
siske, M., et al. (2002). Effects of
cognitive training interventions with
older adults: a randomized con-
trolled trial. JAMA 288, 2271–2281.
Barnes, D. E., and Yaffe, K. (2011). The
projected effect of risk factor reduc-
tion on Alzheimer’s disease preva-
lence. Lancet Neurol. 10, 819–828.
BBC News. (2012). Alzheimer’s
Disease Drug Shelved after
Trial Failure. Available at:
http://www.bbc.co.uk/news/world-
us-canada-19159167 [accessed
August 6, 2012].
Bennett, D. A., Schneider, J. A.,
Tang, Y., Arnold, S. E., and Wil-
son, R. S. (2006). The effect of
social networks on the relation
between Alzheimer’s disease pathol-
ogy and level of cognitive func-
tion in old people: a longitudi-
nal cohort study. Lancet Neurol. 5,
406–412.
Bialystok, E., Craik, F. I., and Freedman,
M. (2007). Bilingualism as a protec-
tion against the onset of symptoms
of dementia. Neuropsychologia 45,
459–464.
Bialystok, E., Craik, F. I., and Luk, G.
(2012). Bilingualism: consequences
for mind and brain.Trends Cogn. Sci.
(Regul. Ed.) 16, 240–250.
Blum, S., Luchsinger, J. A., Manly, J. J.,
Schupf, N., Stern, Y., Brown, T. R.,
et al. (2012). Memory after silent
stroke: hippocampus and infarcts
both matter. Neurology 78, 38–46.
Brookmeyer, R., Johnson, E., Ziegler-
Graham, K., and Arrighi, H. M.
(2007). Forecasting the global
burden of Alzheimer’s disease.
Alzheimers Dement. 3, 186–191.
Buschert, V., Bokde, A. L. W., and Ham-
pel, H. (2010). Cognitive interven-
tion in Alzheimer disease. Nat. Rev.
Neurol. 6, 508–517.
Chui, H. C., Zheng, L., Reed, B. R.,
Vinters, H. V., and Mack, W. J.
(2012). Vascular risk factors and
Alzheimer’s disease: are these risk
factors for plaques and tangles or for
concomitant vascular pathology that
increases the likelihood of demen-
tia? An evidence-based review.
Alzheimers Res. Ther. 4, 1.
Costandi, M. (2012). Fantasy fix. New
Sci. 213, 39–41.
Dardiotis, E., Giamouzi, G., Mastro-
giannis, D., Vogiatzi, C., Skoularigis,
J., Triposkiadis, F., et al. (2012). Cog-
nitive impairment in heart failure.
Cardiol. Res. Pract. 2012, 595821.
Daviglus, M. L., Plassman, B. L., Pirzada,
A., Bell, C. C., Bowen, P. E., Burke, J.
R., et al. (2011). Risk factors and pre-
ventive interventions for Alzheimer
disease.Arch. Neurol. 68, 1185–1190.
de la Torre, J. C. (2004). Is Alzheimer’s
disease a neurodegenerative or a vas-
cular disorder? Data, dogma, and
dialectics. Lancet Neurol. 3, 184–190.
de la Torre, J. C. (2010). Alzheimer’s dis-
ease is incurable but preventable. J.
Alzheimers Dis. 20, 861–870.
Frontiers in Neurology | Stroke March 2013 | Volume 4 | Article 13 | 4
Willis and Hakim Delaying onset of dementia
Debette, S., and Markus, H. S. (2010).
The clinical importance of white
matter hyperintensities on brain
magnetic resonance imaging: sys-
tematic review and meta-analysis.
BMJ 341, c3666.
DeCarli, C., Massaro, J., Harvey, D.,
Hald, J., Tullberg, M., Au, R., et
al. (2005). Measures of brain mor-
phology and infarction in the Fram-
ingham Heart Study: establishing
what is normal. Neurobiol. Aging 26,
491–510.
Denkinger, M. D., Nikolaus, T.,
Denkinger, C., and Lukas, A. (2012).
Physical activity for the preven-
tion of cognitive decline. Current
evidence from observational and
controlled studies. Z. Gerontol.
Geriatr. 45, 11–16.
Deschaintre, Y., Richard, F., Leys, D.,
and Pasquier, F. (2009). Treatment
of vascular risk factors is associated
with slower decline in Alzheimer’s
disease. Neurology 73, 674–680.
Dowling, N. M., Tomaszewski-Farias, S.,
Reed, B. R., Sonnen, J. A., Strauss, M.
E., Schneider, J. A., et al. (2011). Neu-
ropathological associates of mul-
tiple cognitive functions in two
community-based cohorts of older
adults. J. Int. Neuropsychol. Soc. 17,
602–614.
Esiri, M. M., and Chance, S. A. (2012).
Cognitive reserve, cortical plasticity
and resistance to Alzheimer’s dis-
ease. Alzheimers Res. Ther. 4, 7.
Goldberg, I., Auriel, E., Russell, D., and
Korczyn, A. D. (2012). Microem-
bolism, silent brain infarcts and
dementia. J. Neurol. Sci. 322,
250–253.
Goldstein, L. B., Bushnell, C. D., Adams,
R. J., Appel, L. J., Braun, L. T.,
Chaturvedi, S., et al. (2011). Guide-
lines for the primary prevention of
stroke: a guideline for healthcare
professionals from the American
Heart Association/American Stroke
Association. Stroke 42, 517–584.
Gorelick, P. B., Scuteri, A., Black, S.
E., Decarli, C., Greenberg, S. M.,
Iadecola, C., et al. (2011). Vas-
cular contributions to cognitive
impairment and dementia: a state-
ment for healthcare professionals
from the American Heart Associ-
ation/American Stroke Association.
Stroke 42, 2672–2713.
Grinberg, L. T., and Heinsen, H. (2010).
Toward a pathological definition of
vascular dementia. J. Neurol. Sci.
299, 136–138.
Hachinski, V., Iadecola, C., Petersen,
R. C., Breteler, M. M., Nyenhuis,
D. L., Black, S. E., et al. (2006).
National Institute of Neurologi-
cal Disorders and Stroke-Canadian
Stroke Network vascular cognitive
impairment harmonization stan-
dards. Stroke 37, 2220–2241.
Hakim, A. M. (2011). Depression,
strokes and dementia: new biological
insights into an unfortunate path-
way. Cardiovasc. Psychiatry Neurol.
2011, 649629.
Hendrie, H. C., Ogunniyi, A., Hall, K.
S., Baiyewu, O., Unverzagt, F. W.,
Gureje, O., et al. (2001). Incidence
of dementia and Alzheimer dis-
ease in 2 communities. JAMA 285,
739–747.
Jeerakathil, T., Wolf, P. A., Beiser,
A., Hald, J. K., Au, R., Kase, C.
S., et al. (2004). Cerebral microb-
leeds: prevalence and associations
with cardiovascular risk factors in
the Framingham study. Stroke 35,
1831–1835.
Korczyn,A. D.,Vakhapova,V., and Grin-
berg, L. T. (2012). Vascular demen-
tia. J. Neurol. Sci. 322, 2–10.
Kroke, A., Boeing, H., Rossnagel, K., and
Willich, S. N. (2003). History of the
concept of ‘levels of evidence’ and
their current status in relation to
primary prevention through lifestyle
interventions. Public Health Nutr. 7,
279–284.
Lee, E. B. (2011). Obesity, leptin, and
Alzheimer’s disease. Ann. N. Y. Acad.
Sci. 1243, 15–29.
Leys, D., Hénon, H., MacKowiak-
Cordoliani, M.-A., and Pasquier, F.
(2005). Poststroke dementia. Lancet
Neurol. 4, 752–759.
Lu, F. P., Lin, K. P., and Kuo,
H. K. (2009). Diabetes and the
risk of multi-system aging phe-
notypes: a systematic review and
meta-analysis. PLoS ONE 4:e4144.
doi:10.1371/journal.pone.0004144
Mangialasche, F., Kivipelto, M.,
Solomon, A., and Fratiglioni, L.
(2012). Dementia prevention: cur-
rent epidemiological evidence and
future perspective. Alzheimers Res.
Ther. 4, 6.
Meng, X., and D’Arcy, C. (2012).
Education and dementia in the
context of the cognitive reserve
hypothesis: a systematic review
with meta-analysis and qualita-
tive analysis. PLoS ONE 7:e38268.
doi:10.1371/journal.pone.0038268
Moller, J. T., Cluitmans, P., Rasmussen,
L. S., Houx, P., Rasmussen, H.,
Canet, J., et al. (1998). Long-term
postoperative cognitive dysfunction
in the elderly ISPOCD1 study:
international study of postoperative
cognitive dysfunction. Lancet 351,
857–861.
Nagai, M., Hoshide, S., and Kario, K.
(2010). Hypertension and dementia.
Am. J. Hypertens. 23, 116–124.
National Institutes of Health. (2010).
Consensus Development Conference
Statement on Preventing Alzheimer’s
Disease and Cognitive Decline.
Bethesda: National Institutes of
Health.
Neuropathology Group. Medical
Research Council Cognitive Func-
tion and Aging Study. (2001).
Pathological correlates of late-
onset dementia in a multicentre,
community-based population in
England and Wales. Lancet 357,
169–175.
Ojala-Oksala, J., Jokinen, H., Kopsi,
V., Lehtonen, K., Luukkonen, L.,
Paukkunen, A., et al. (2012). Educa-
tional history is an independent pre-
dictor of cognitive deficits and long-
term survival in postacute patients
with mild to moderate ischemic
stroke. Stroke 43, 2931–2935.
Owen, A. M., Hampshire, A., Grahn, J.
A., Stenton, R., Dajani, S., Burns, A.
S., et al. (2010). Putting brain train-
ing to the test. Nature 465, 775–778.
Patterson, C., Feightner, J., Garcia, A.,
and MacKnight, C. (2007). Gen-
eral risk factors for dementia: a sys-
tematic evidence review. Alzheimers
Dement. 3, 341–347.
Pendlebury, S. T., and Rothwell, P. M.
(2009). Prevalence, incidence, and
factors associated with pre-stroke
and post-stroke dementia: a system-
atic review and meta-analysis.Lancet
Neurol. 8, 1006–1018.
Pimentel-Coelho, P. M., and Rivest, S.
(2012). The early contribution of
cerebrovascular factors to the patho-
genesis of Alzheimer’s disease. Eur. J.
Neurosci. 35, 1917–1937.
Poels, M. M., Vernooij, M. W., Ikram,
M. A., Hofman, A., Krestin, G. P.,
van der Lugt, A., et al. (2010).
Prevalence and risk factors of cere-
bral microbleeds and update of the
Rotterdam Scan Study. Stroke 41,
s103–s106.
Prince, M., Acosta, D., Ferri, C. P.,
Guerra, M., Huang, Y., Llibre-
Rodriguez, J. J., et al. (2012).
Dementia incidence and mortality
in middle-income countries, and
associations with indicators of cog-
nitive reserve: a 10/66 Demen-
tia Research Group population-
based cohort study. Lancet 380,
50–58.
Prins, N. D., van Dijk, E. J., den Heijer,
T.,Vermeer, S. E., Jolles, J., Koudstaal,
P. J., et al. (2005). Cerebral small-
vessel disease and decline in infor-
mation processing speed, executive
function and memory. Brain 128,
2034–2041.
Purandare, N., Burns, A., Daly, K. J.,
Hardicre, J., Morris, J., Macfarlane,
G., et al. (2006). Cerebral emboli
as a potential cause of Alzheimer’s
disease and vascular dementia:
case-control study. BMJ 332,
1119–1124.
Purandare, N., Burns, A., Morris,
J., Perry, E. P., Wren, J., and
McCollum, C. (2012). Association
of cerebral emboli with accel-
erated cognitive deterioration in
Alzheimer’s disease and vascular
dementia. Am. J. Psychiatry 169,
300–308.
Qiu, C. (2012). Preventing Alzheimer’s
disease by targeting vascular risk fac-
tors: hope and gap. J. Alzheimers Dis.
32, 721–731.
Romàn, G. C. (2002a). On the history
of lacunes, etat criblé, and the white
matter lesions of vascular dementia.
Cerebrovasc. Dis. 13, 1–6.
Romàn, G. C. (2002b). Vascular demen-
tia may be the most common form
of dementia in the elderly. J. Neurol.
Sci. 203–204, 7–10.
Romàn, G. C., Nash, D. T., and Fil-
lit, H. (2012). Translating current
knowledge into dementia preven-
tion. Alzheimer Dis. Assoc. Disord. 4,
295–299.
Rusanen, M., Kivipelto, M., Quesen-
berry, C. P., Zhou, J., and Whit-
mer, R. A. (2010). Heavy smok-
ing in midlife and long-term risk
of Alzheimer disease and vascular
dementia. Arch. Intern. Med. 171,
333–339.
Schneider, J. A., Arvanitakis, Z., Bang,
W., and Bennett, D. A. (2007).
Mixed brain pathologies account for
most dementia cases in community-
dwelling older persons. Neurology
69, 2197–2204.
Schneider, J. A., Arvanitakis, Z., Leur-
gans, S. E., and Bennett, D. A. (2009).
The neuropathology of probable
Alzheimer disease and mild cogni-
tive impairment. Ann. Neurol. 66,
200–208.
Schneider, J. A., and Bennett, D. A.
(2010). Where vascular meets neu-
rodegenerative disease. Stroke 41,
s144–s146.
Schrijvers, E. M., Verhaaren, B. F.,
Koudstaal, P. J., Hofman, A.,
Ikram, M. A., and Breteler, M.
M. (2012). Is dementia incidence
declining? Trends in demen-
tia incidence since 1990 in the
Rotterdam Study. Neurology 78,
1456–1463.
Snowdon, D. A., Greiner, L. H., Mor-
timer, J. A., Riley, K. P., Greiner, P.
A., and Markesbery, W. R. (1997).
Brain infarction and the clini-
cal expression of Alzheimer dis-
ease. The Nun Study. JAMA 277,
813–817.
www.frontiersin.org March 2013 | Volume 4 | Article 13 | 5
Willis and Hakim Delaying onset of dementia
Solfrizzi,V., Panza, F., Frisardi,V., Seripa,
D., Logroscino, G., Imbimbo, B. P.,
et al. (2011). Diet and Alzheimer’s
disease risk factors for prevention:
the current evidence. Expert Rev.
Neurother. 11, 677–708.
Spence, D. (2012). Bad medicine:
dementia. BMJ 344, e3859.
Stern, Y. (2002). What is cognitive
reserve? Theory and research appli-
cation of the reserve concept. J. Int.
Neuropsychol. Soc. 8, 448–460.
Stern, Y. (2006). Cognitive reserve and
Alzheimer disease. Alzheimer Dis.
Assoc. Disord. 20, 112–117.
Sundar, U., and Adwani, S. (2010). Post-
stroke cognitive impairment at 3
months. Ann Indian Acad. Neurol.
13, 42–46.
Teich, A. F., and Arancio, O. (2012).
Is the amyloid hypothesis of
Alzheimer’s disease therapeutically
relevant? Biochem. J. 446, 165–177.
van Vliet, P. (2012). Cholesterol
and late-life cognitive decline. J.
Alzheimers Dis. 30, s147–s162.
Vellas, B., Coley, N., Ousset, P.-
J., Berrut, G., Dartigues, J.-F.,
Dubois, B., et al. (2012). Long-
term use of standardised ginkgo
biloba extract for the prevention
of Alzheimer’s disease (GuidAge):
a randomised placebo-controlled
trial. Lancet Neurol. 11, 851–859.
Vermeer, S. E., Longstreth, W. T., and
Koudstaal, P. J. (2007). Silent brain
infarcts: a systematic review. Lancet
Neurol. 6, 611–619.
Vermeer, S. E., Prins, N. D., den Hei-
jer, T., Hofman, A., Koudstaal, P. J.,
and Breteler, M. M. (2003a). Silent
brain infarcts and the risk of demen-
tia and cognitive decline: the Rotter-
dam Scan Study.N. Engl. J.Med. 348,
1215–1222.
Vermeer, S. E., Hollander, M., van
Dijk, E. J., Hofman, A., Koud-
staal, P. J., and Breteler, M. M.
(2003b). Silent brain infarcts and
white-matter lesions increase stroke
risk in the general population: the
Rotterdam Scan Study. Stroke 34,
1126–1129.
Viswanathan, A., and Chabriat, H.
(2006). Cerebral microhemorrhage.
Stroke 37, 550–555.
Werring, D. J., Frazer, D. W., Cow-
ard, L. J., Losseff, N. A., Watt, H.,
Cipolotti, L., et al. (2004). Cognitive
dysfunction in patients with cere-
bral microbleeds on T2∗-weighted
gradient-echo MRI. Brain 127,
2265–2275.
Willis, B. L., Gao, A., Leonard, D.,
Defina, L. F., and Berry, J. D.
(2012). Midlife fitness and the devel-
opment of chronic conditions in
later life. Arch. Intern. Med. 172,
1333–1340.
World Health Organization and
Alzheimer’s Disease International.
(2012). Dementia: a Public Health
Priority. Geneva: World Health
Organization Press.
Zieren, N., Duering, M., Peters, N.,
Reyes, S., Jouvent, E., Hervé, D.,
et al. (2013). Education modifies
the relation of vascular pathol-
ogy to cognitive function: cog-
nitive reserve in cerebral autoso-
mal dominant arteriopathy with
subcortical infarcts and leukoen-
cephalopathy. Neurobiol. Aging 34,
400–407.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 12 December 2012; accepted:
04 February 2013; published online: 21
March 2013.
Citation: Willis KJ and Hakim AM
(2013) Stroke prevention and cogni-
tive reserve: emerging approaches to
modifying risk and delaying onset of
dementia. Front. Neurol. 4:13. doi:
10.3389/fneur.2013.00013
This article was submitted to Frontiers
in Stroke, a specialty of Frontiers in
Neurology.
Copyright©2013Willis andHakim.This
is an open-access article distributed under
the terms of the Creative Commons Attri-
bution License, which permits use, distri-
bution and reproduction in other forums,
provided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
Frontiers in Neurology | Stroke March 2013 | Volume 4 | Article 13 | 6
